USPTO serial 79428652
ZEAL&
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- BLAZICH, JOAN MICHELE
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).
Need help with ZEAL&?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of diseases and disorders in humans, namely, endocrine, nutritional, metabolic, immune, blood, nervous system, sensory organ, musculoskeletal, connective tissue, circulatory, respiratory, digestive, genitourinary, and skin disorders, diabetes, obesity, gastrointestinal diseases and conditions such as Congenital HyperInsulinism (CHI), hypoglycemia, Short Bowel Syndrome (SBS), and chronic inflammation, Inflammatory Bowel Disease (IBD) and Metabolic dysfunction-associated steatohepatitis (MASH); delivery devices containing pharmaceutical products, namely, syringes sold filled with pharmaceutical preparations for the treatment of diseases and disorders in humans, namely, endocrine, nutritional, metabolic, immune, blood, nervous system, sensory organ, musculoskeletal, connective tissue, circulatory, respiratory, digestive, genitourinary, and skin disorders, diabetes, obesity, gastrointestinal diseases and conditions such as Congenital HyperInsulinism (CHI), hypoglycemia, Short Bowel Syndrome (SBS), and chronic inflammation, Inflammatory Bowel Disease (IBD) and Metabolic dysfunction-associated steatohepatitis (MASH); chemical preparations for use in medical devices, namely, chemical preparations for pharmaceutical purposes for the treatment of diseases and disorders in humans, namely, endocrine, nutritional, metabolic, immune, blood, nervous system, sensory organ, musculoskeletal, connective tissue, circulatory, respiratory, digestive, genitourinary, and skin disorders, diabetes, obesity, gastrointestinal diseases and conditions such as Congenital HyperInsulinism (CHI), hypoglycemia, Short Bowel Syndrome (SBS), and chronic inflammation, Inflammatory Bowel Disease (IBD) and Metabolic dysfunction-associated steatohepatitis (MASH) | ACTIVE | — |
| 009 | Downloadable electronic publications, namely, leaflets, books, booklets, handouts, magazines as well as medical, instructional and teaching material, all in the field of diabetes, obesity, and gastrointestinal diseases; downloadable software applications for use with mobile devices for monitoring and the management of diseases and illnesses in human beings; computer hardware and downloadable software, for use with medical injection devices for collecting, transmitting, and displaying medical data; downloadable medical software for the management of diseases and illnesses in human beings; downloadable software intended for medical purposes that perform these purposes without being part of a medical device, namely, for monitoring and managing diseases in humans | ACTIVE | — |
| 010 | Medical apparatus and instruments being syringes, insulin pumps, adhesive medical pads; medical apparatus and instruments for reconstitution and injection of pharmaceutical preparations; medical apparatus and instruments, namely, injection devices for administration of pharmaceutical preparations, medical infusion pumps, infusion pump controllers, adhesive infusion devices for administering drugs; digitally connected medical devices for monitoring the dispensation of pharmaceutical preparations for use in connection with the management of diseases and illnesses in the human body; medical and surgical apparatus and instruments, namely, injection devices for the administration of pharmaceutical preparations and the wireless transmission of medical data in connection with the management of diseases and illnesses in the human body; medical devices, namely, automatic needle insertion devices, protection caps for syringes and medical pens; hypodermic needles for injections; cartridges and carpules, sold empty, for administration pharmaceutical preparations | ACTIVE | — |
| 042 | Scientific and technological services and research and design relating thereto, namely, scientific research and development in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; providing scientific research information on diseases and illnesses in the human body; providing websites and hosting of mobile apps featuring technology that enable users to record, track, and generate reports regarding the condition, treatment and the management of diseases and illnesses in the human body; computer services, namely, providing a website featuring technology enabling users to access data concerning medical analysis and management of diseases and illnesses in the human body; scientific industrial analysis and research services in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; medical, biological, biotechnological, genetic, medical laboratory research and pharmaceutical research, pharmaceutical design and development services; medical laboratory research in the field of medicine, pharmaceuticals, genetics, biology and biotechnology; information and consultancy services relating to all the aforesaid | ACTIVE | — |
| 044 | Providing medical services via websites and mobile apps for the management of diseases and illnesses in the human body; providing medical information and medical counselling relating to the management of diseases and illnesses in the human body. | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ZEALAND PHARMA A/S
- Other trademarks owned by ZEALAND PHARMA A/S
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ZEAL&
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 4, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 4, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 29, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 6, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 3, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 3, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 3, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 3, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 12, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 12, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 12, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 1, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 17, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 16, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Oct 16, 2025 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Oct 15, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 14, 2025 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 1, 2025 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 1, 2025 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 24, 2025 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |